Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.
Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, the kidney will produce and secrete erythropoietin to increase the production of red blood cells by targeting CFU-E, proerythroblast and basophilic erythroblast subsets in the differentiation. Erythropoietin has its primary effect on red blood cell progenitors and precursors (which are found in the bone marrow in humans) by promoting their survival through protecting these cells from apoptosis, or cell death. The classification of erythropoietin includes epoetin-alfa, epoetin-beta, darbepoetin-alfa and others. The proportion of epoetin-alfa in 2019 is about 58%. Erythropoietin is widely used for anemia and kidney disorders. The most proportion of Erythropoietin used in Kidney Disorders, and the market share in 2019 is 45%.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Erythropoietin market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Erythropoietin market. Detailed analysis of key players, along with key growth strategies adopted by Erythropoietin industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
3SBio
Emcure
Biocon
Johnson & Johnson
Roche
LG Life Sciences
Galenica
Amgen
Kyowa Hakko Kirin
By Type:
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others
By End-User:
Anemia
Kidney Disorders
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Erythropoietin Market
-
1.3 Market Segment by Type
-
1.3.1 China Erythropoietin Market Size and Growth Rate of Epoetin-alfa from 2016 to 2027
-
1.3.2 China Erythropoietin Market Size and Growth Rate of Epoetin-beta from 2016 to 2027
-
1.3.3 China Erythropoietin Market Size and Growth Rate of Darbepoetin-alfa from 2016 to 2027
-
1.3.4 China Erythropoietin Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Erythropoietin Market Size and Growth Rate of Anemia from 2016 to 2027
-
1.4.2 China Erythropoietin Market Size and Growth Rate of Kidney Disorders from 2016 to 2027
-
1.4.3 China Erythropoietin Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Erythropoietin Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Erythropoietin Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Erythropoietin Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Erythropoietin Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Erythropoietin Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Erythropoietin Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Erythropoietin Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Erythropoietin Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Erythropoietin by Major Types
-
3.4.1 Market Size and Growth Rate of Epoetin-alfa
-
3.4.2 Market Size and Growth Rate of Epoetin-beta
-
3.4.3 Market Size and Growth Rate of Darbepoetin-alfa
-
3.4.4 Market Size and Growth Rate of Others
4 Segmentation of Erythropoietin Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Erythropoietin by Major End-Users
-
4.4.1 Market Size and Growth Rate of Erythropoietin in Anemia
-
4.4.2 Market Size and Growth Rate of Erythropoietin in Kidney Disorders
-
4.4.3 Market Size and Growth Rate of Erythropoietin in Others
5 Market Analysis by Regions
-
5.1 China Erythropoietin Production Analysis by Regions
-
5.2 China Erythropoietin Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Erythropoietin Landscape Analysis
-
6.1 North China Erythropoietin Landscape Analysis by Major Types
-
6.2 North China Erythropoietin Landscape Analysis by Major End-Users
7 Central China Erythropoietin Landscape Analysis
-
7.1 Central China Erythropoietin Landscape Analysis by Major Types
-
7.2 Central China Erythropoietin Landscape Analysis by Major End-Users
8 South China Erythropoietin Landscape Analysis
-
8.1 South China Erythropoietin Landscape Analysis by Major Types
-
8.2 South China Erythropoietin Landscape Analysis by Major End-Users
9 East China Erythropoietin Landscape Analysis
-
9.1 East China Erythropoietin Landscape Analysis by Major Types
-
9.2 East China Erythropoietin Landscape Analysis by Major End-Users
10 Northeast China Erythropoietin Landscape Analysis
-
10.1 Northeast China Erythropoietin Landscape Analysis by Major Types
-
10.2 Northeast China Erythropoietin Landscape Analysis by Major End-Users
11 Southwest China Erythropoietin Landscape Analysis
-
11.1 Southwest China Erythropoietin Landscape Analysis by Major Types
-
11.2 Southwest China Erythropoietin Landscape Analysis by Major End-Users
12 Northwest China Erythropoietin Landscape Analysis
-
12.1 Northwest China Erythropoietin Landscape Analysis by Major Types
-
12.2 Northwest China Erythropoietin Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 3SBio
-
13.1.1 3SBio Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Emcure
-
13.2.1 Emcure Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Biocon
-
13.3.1 Biocon Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Johnson & Johnson
-
13.4.1 Johnson & Johnson Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Roche
-
13.5.1 Roche Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 LG Life Sciences
-
13.6.1 LG Life Sciences Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Galenica
-
13.7.1 Galenica Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Amgen
-
13.8.1 Amgen Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Kyowa Hakko Kirin
-
13.9.1 Kyowa Hakko Kirin Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Erythropoietin Market Size and Growth Rate of Epoetin-alfa from 2016 to 2027
-
Figure China Erythropoietin Market Size and Growth Rate of Epoetin-beta from 2016 to 2027
-
Figure China Erythropoietin Market Size and Growth Rate of Darbepoetin-alfa from 2016 to 2027
-
Figure China Erythropoietin Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Erythropoietin Market Size and Growth Rate of Anemia from 2016 to 2027
-
Figure China Erythropoietin Market Size and Growth Rate of Kidney Disorders from 2016 to 2027
-
Figure China Erythropoietin Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Erythropoietin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Erythropoietin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Erythropoietin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Erythropoietin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Erythropoietin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Erythropoietin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Erythropoietin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Erythropoietin Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Erythropoietin
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Erythropoietin by Different Types from 2016 to 2027
-
Table Consumption Share of Erythropoietin by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Epoetin-alfa
-
Figure Market Size and Growth Rate of Epoetin-beta
-
Figure Market Size and Growth Rate of Darbepoetin-alfa
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Erythropoietin by Different End-Users from 2016 to 2027
-
Table Consumption Share of Erythropoietin by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Anemia
-
Figure Market Size and Growth Rate of Kidney Disorders
-
Figure Market Size and Growth Rate of Others
-
Table China Erythropoietin Production by Regions
-
Table China Erythropoietin Production Share by Regions
-
Figure China Erythropoietin Production Share by Regions in 2016
-
Figure China Erythropoietin Production Share by Regions in 2021
-
Figure China Erythropoietin Production Share by Regions in 2027
-
Table China Erythropoietin Consumption by Regions
-
Table China Erythropoietin Consumption Share by Regions
-
Figure China Erythropoietin Consumption Share by Regions in 2016
-
Figure China Erythropoietin Consumption Share by Regions in 2021
-
Figure China Erythropoietin Consumption Share by Regions in 2027
-
Table North China Erythropoietin Consumption by Types from 2016 to 2027
-
Table North China Erythropoietin Consumption Share by Types from 2016 to 2027
-
Figure North China Erythropoietin Consumption Share by Types in 2016
-
Figure North China Erythropoietin Consumption Share by Types in 2021
-
Figure North China Erythropoietin Consumption Share by Types in 2027
-
Table North China Erythropoietin Consumption by End-Users from 2016 to 2027
-
Table North China Erythropoietin Consumption Share by End-Users from 2016 to 2027
-
Figure North China Erythropoietin Consumption Share by End-Users in 2016
-
Figure North China Erythropoietin Consumption Share by End-Users in 2021
-
Figure North China Erythropoietin Consumption Share by End-Users in 2027
-
Table Central China Erythropoietin Consumption by Types from 2016 to 2027
-
Table Central China Erythropoietin Consumption Share by Types from 2016 to 2027
-
Figure Central China Erythropoietin Consumption Share by Types in 2016
-
Figure Central China Erythropoietin Consumption Share by Types in 2021
-
Figure Central China Erythropoietin Consumption Share by Types in 2027
-
Table Central China Erythropoietin Consumption by End-Users from 2016 to 2027
-
Table Central China Erythropoietin Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Erythropoietin Consumption Share by End-Users in 2016
-
Figure Central China Erythropoietin Consumption Share by End-Users in 2021
-
Figure Central China Erythropoietin Consumption Share by End-Users in 2027
-
Table South China Erythropoietin Consumption by Types from 2016 to 2027
-
Table South China Erythropoietin Consumption Share by Types from 2016 to 2027
-
Figure South China Erythropoietin Consumption Share by Types in 2016
-
Figure South China Erythropoietin Consumption Share by Types in 2021
-
Figure South China Erythropoietin Consumption Share by Types in 2027
-
Table South China Erythropoietin Consumption by End-Users from 2016 to 2027
-
Table South China Erythropoietin Consumption Share by End-Users from 2016 to 2027
-
Figure South China Erythropoietin Consumption Share by End-Users in 2016
-
Figure South China Erythropoietin Consumption Share by End-Users in 2021
-
Figure South China Erythropoietin Consumption Share by End-Users in 2027
-
Table East China Erythropoietin Consumption by Types from 2016 to 2027
-
Table East China Erythropoietin Consumption Share by Types from 2016 to 2027
-
Figure East China Erythropoietin Consumption Share by Types in 2016
-
Figure East China Erythropoietin Consumption Share by Types in 2021
-
Figure East China Erythropoietin Consumption Share by Types in 2027
-
Table East China Erythropoietin Consumption by End-Users from 2016 to 2027
-
Table East China Erythropoietin Consumption Share by End-Users from 2016 to 2027
-
Figure East China Erythropoietin Consumption Share by End-Users in 2016
-
Figure East China Erythropoietin Consumption Share by End-Users in 2021
-
Figure East China Erythropoietin Consumption Share by End-Users in 2027
-
Table Northeast China Erythropoietin Consumption by Types from 2016 to 2027
-
Table Northeast China Erythropoietin Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Erythropoietin Consumption Share by Types in 2016
-
Figure Northeast China Erythropoietin Consumption Share by Types in 2021
-
Figure Northeast China Erythropoietin Consumption Share by Types in 2027
-
Table Northeast China Erythropoietin Consumption by End-Users from 2016 to 2027
-
Table Northeast China Erythropoietin Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Erythropoietin Consumption Share by End-Users in 2016
-
Figure Northeast China Erythropoietin Consumption Share by End-Users in 2021
-
Figure Northeast China Erythropoietin Consumption Share by End-Users in 2027
-
Table Southwest China Erythropoietin Consumption by Types from 2016 to 2027
-
Table Southwest China Erythropoietin Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Erythropoietin Consumption Share by Types in 2016
-
Figure Southwest China Erythropoietin Consumption Share by Types in 2021
-
Figure Southwest China Erythropoietin Consumption Share by Types in 2027
-
Table Southwest China Erythropoietin Consumption by End-Users from 2016 to 2027
-
Table Southwest China Erythropoietin Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Erythropoietin Consumption Share by End-Users in 2016
-
Figure Southwest China Erythropoietin Consumption Share by End-Users in 2021
-
Figure Southwest China Erythropoietin Consumption Share by End-Users in 2027
-
Table Northwest China Erythropoietin Consumption by Types from 2016 to 2027
-
Table Northwest China Erythropoietin Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Erythropoietin Consumption Share by Types in 2016
-
Figure Northwest China Erythropoietin Consumption Share by Types in 2021
-
Figure Northwest China Erythropoietin Consumption Share by Types in 2027
-
Table Northwest China Erythropoietin Consumption by End-Users from 2016 to 2027
-
Table Northwest China Erythropoietin Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Erythropoietin Consumption Share by End-Users in 2016
-
Figure Northwest China Erythropoietin Consumption Share by End-Users in 2021
-
Figure Northwest China Erythropoietin Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of 3SBio
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of 3SBio
-
Figure Sales and Growth Rate Analysis of 3SBio
-
Figure Revenue and Market Share Analysis of 3SBio
-
Table Product and Service Introduction of 3SBio
-
Table Company Profile and Development Status of Emcure
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emcure
-
Figure Sales and Growth Rate Analysis of Emcure
-
Figure Revenue and Market Share Analysis of Emcure
-
Table Product and Service Introduction of Emcure
-
Table Company Profile and Development Status of Biocon
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon
-
Figure Sales and Growth Rate Analysis of Biocon
-
Figure Revenue and Market Share Analysis of Biocon
-
Table Product and Service Introduction of Biocon
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of LG Life Sciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of LG Life Sciences
-
Figure Sales and Growth Rate Analysis of LG Life Sciences
-
Figure Revenue and Market Share Analysis of LG Life Sciences
-
Table Product and Service Introduction of LG Life Sciences
-
Table Company Profile and Development Status of Galenica
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Galenica
-
Figure Sales and Growth Rate Analysis of Galenica
-
Figure Revenue and Market Share Analysis of Galenica
-
Table Product and Service Introduction of Galenica
-
Table Company Profile and Development Status of Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
-
Figure Sales and Growth Rate Analysis of Amgen
-
Figure Revenue and Market Share Analysis of Amgen
-
Table Product and Service Introduction of Amgen
-
Table Company Profile and Development Status of Kyowa Hakko Kirin
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kyowa Hakko Kirin
-
Figure Sales and Growth Rate Analysis of Kyowa Hakko Kirin
-
Figure Revenue and Market Share Analysis of Kyowa Hakko Kirin
-
Table Product and Service Introduction of Kyowa Hakko Kirin
-
